FDA drug regulator resigns amid bribery and defamation allegations, denies wrongdoing and claims retaliation for criticizing agency officials.
Meta's Q3 profit slashed by a $15.93B tax charge, but the company remains focused on AI investment and expansion.
Sam Sifton, a veteran of The New York Times, takes over as the new host of the newspaper's flagship newsletter, The Morning, aiming to guide readers through global news, culture, and lifestyle coverage.
FDA drug regulator resigns amid bribery and defamation allegations, denies wrongdoing and claims retaliation for criticizing agency officials.
Meta's Q3 profit slashed by a $15.93B tax charge, but the company remains focused on AI investment and expansion.
Sam Sifton, a veteran of The New York Times, takes over as the new host of the newspaper's flagship newsletter, The Morning, aiming to guide readers through global news, culture, and lifestyle coverage.